Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models

References

• Albores A, Cebrián ME, Bach PH, Connelly JC, Hinton RH, Bridges JW. 1989. Sodium arsenite induced alterations in bilirubin excretion and heme metabolism. J Biochem Toxicol. 4(2):73–78. doi:10.1002/jbt.2570040202.
   PubMedGoogle Scholar
• Albores A, Cebrian ME, Connelly JC, Bach PH, Bridges JW. 1992. Effects of arsenite on hepatic mixed-function oxidase activity in rats. Xenobiotica. 22(5):591–597. doi:10.3109/00498259209053122.
   PubMed Web of Science ®Google Scholar
• Albores A, Sinal CJ, Cherian MG, Bend JR. 1995. Selective increase of rat lung cytochrome P450 1A1 dependent monooxygenase activity after acute sodium arsenite administration. Can J Physiol Pharmacol. 73(1):153–158. doi:10.1139/y95-023.
   PubMed Web of Science ®Google Scholar
• Alqahtani MA, El-Ghiaty MA, El-Kadi AOS. 2023. Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro. J Biochem Mol Toxicol. 37(2):e23243. doi:10.1002/jbt.23243.
   PubMed Web of Science ®Google Scholar
• Anwar-Mohamed A, Abdelhamid G, Amara IE, El-Kadi AO. 2012. Differential modulation of aryl hydrocarbon receptor regulated enzymes by arsenite in the kidney, lung, and heart of C57BL/6 mice. Arch Toxicol. 86(6):897–910. doi:10.1007/s00204-012-0855-x.
   PubMed Web of Science ®Google Scholar
• Anwar-Mohamed A, Abdelhamid G, Amara IE, El-Kadi AO. 2013. Differential modulation of cytochrome P450 1a1 by arsenite in vivo and in vitro in C57BL/6 mice. Free Radic Biol Med. 58:52–63. Epub 2013/02/02. doi:10.1016/j.freeradbiomed.2013.01.012.
   PubMed Web of Science ®Google Scholar
• Anwar-Mohamed A, El-Sherbeni A, Kim SH, Elshenawy OH, Althurwi HN, Zordoky BNM, El-Kadi AOS. 2013. Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl/6 mice. Xenobiotica. 43(8):719–729. doi:10.3109/00498254.2012.754113.
   PubMed Web of Science ®Google Scholar
• Anwar-Mohamed A, El-Sherbeni AA, Kim SH, Althurwi HN, Zordoky BN, El-Kadi AO. 2012. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart. Xenobiotica. 42(12):1235–1247. doi:10.3109/00498254.2012.693971.
   PubMed Web of Science ®Google Scholar
• Anwar-Mohamed A, Elbekai RH, El-Kadi AO. 2009. Regulation of CYP1A1 by heavy metals and consequences for drug metabolism. Expert Opin Drug Metab Toxicol. 5(5):501–521. doi:10.1517/17425250902918302.
   PubMed Web of Science ®Google Scholar
• Anwar-Mohamed A, Elshenawy OH, El-Sherbeni AA, Abdelrady M, El-Kadi AO. 2014. Acute arsenic treatment alters arachidonic acid and its associated metabolite levels in the brain of C57Bl/6 mice. Can J Physiol Pharmacol. 92(8):693–702. Epub 2014/07/30. doi:10.1139/cjpp-2014-0136.
   PubMed Web of Science ®Google Scholar
• Anwar-Mohamed A, Klotz LO, El-Kadi AO. 2012. Inhibition of heme oxygenase-1 partially reverses the arsenite-mediated decrease of CYP1A1, CYP1A2, CYP3A23, and CYP3A2 catalytic activity in isolated rat hepatocytes. Drug Metab Dispos. 40(3):504–514. doi:10.1124/dmd.111.042564.
   PubMed Web of Science ®Google Scholar
• ATSDR. 2007. Toxicological profile for arsenic. Atlanta: Agency for Toxic Substances and Disease Registery.
   Google Scholar
• Bashir S, Sharma Y, Irshad M, Gupta SD, Dogra TD. 2006. Arsenic-induced cell death in liver and brain of experimental rats. Basic Clin Pharmacol Toxicol. 98(1):38–43. doi:10.1111/j.1742-7843.2006.pto_170.x.
   PubMed Web of Science ®Google Scholar
• Bonzo JA, Chen S, Galijatovic A, Tukey RH. 2005. Arsenite inhibition of CYP1A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin is independent of cell cycle arrest. Mol Pharmacol. 67(4):1247–1256. doi:10.1124/mol.104.006130.
   PubMed Web of Science ®Google Scholar
• Carnahan VE, Redinbo MR. 2005. Structure and function of the human nuclear xenobiotic receptor PXR. Curr Drug Metab. 6(4):357–367. doi:10.2174/1389200054633844.
   Google Scholar
• Cebrián ME, Albores A, Connelly JC, Bridges JW. 1988. Assessment of arsenic effects on cytosolic heme status using tryptophan pyrrolase as an index. J Biochem Toxicol. 3(2):77–86. doi:10.1002/jbt.2570030203.
   PubMedGoogle Scholar
• Dalton TP, Shertzer HG, Puga A. 1999. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol. 39(1):67–101. doi:10.1146/annurev.pharmtox.39.1.67.
   PubMed Web of Science ®Google Scholar
• El-Ghiaty MA, Alqahtani MA, El-Kadi AOS. 2022. Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: a role of heme oxygenase 1. Chem Biol Interact. 364:110049. Epub 2022/07/26 doi:10.1016/j.cbi.2022.110049.
   PubMed Web of Science ®Google Scholar
• El-Ghiaty MA, Alqahtani MA, El-Kadi AOS. 2023a. Arsenic trioxide (ATO) up-regulates cytochrome P450 1A (CYP1A) enzymes in murine hepatoma Hepa-1c1c7 cell line. Environ Toxicol Pharmacol. 101:104214. doi:10.1016/j.etap.2023.104214.
   PubMed Web of Science ®Google Scholar
• El-Ghiaty MA, Alqahtani MA, El-Kadi AOS. 2023b. Modulation of cytochrome P450 1A (CYP1A) enzymes by monomethylmonothioarsonic acid (MMMTA(V)) in vivo and in vitro. Chem Biol Interact. 376:110447. Epub 2023/03/10. doi:10.1016/j.cbi.2023.110447.
   PubMed Web of Science ®Google Scholar
• El-Ghiaty MA, El-Kadi AOS. 2021. Arsenic: various species with different effects on cytochrome P450 regulation in humans. Excli J. 20:1184–1242. Epub 2021/09/14. PubMed PMID: 34512225; PubMed Central PMCID: PMC8419240. doi:10.17179/excli2021-3890.
   PubMed Web of Science ®Google Scholar
• El-Ghiaty MA, El-Kadi AOS. 2023. The duality of arsenic metabolism: impact on human health. Annu Rev Pharmacol Toxicol. 63:341–358. doi:10.1146/annurev-pharmtox-051921-020936.
   PubMed Web of Science ®Google Scholar
• El-Ghiaty MA, Shoieb SM, El-Kadi AOS. 2020. Cytochrome P450-mediated drug interactions in COVID-19 patients: current findings and possible mechanisms. Med Hypotheses. 144:110033. doi:10.1016/j.mehy.2020.110033.
   PubMed Web of Science ®Google Scholar
• Elbekai RH, El-Kadi AO. 2004. Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium. Toxicology. 202(3):249–269. doi:10.1016/j.tox.2004.05.009.
   PubMed Web of Science ®Google Scholar
• Elbekai RH, El-Kadi AO. 2007. Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium. Toxicol Lett. 172(3):106–119. doi:10.1016/j.toxlet.2007.05.009.
   PubMed Web of Science ®Google Scholar
• Elshenawy OH, Abdelhamid G, Althurwi HN, El-Kadi AOS. 2018. Dimethylarsinic acid modulates the aryl hydrocarbon receptor-regulated genes in C57BL/6 mice: in vivo study. Xenobiotica. 48(2):124–134. doi:10.1080/00498254.2017.1289423.
   PubMedGoogle Scholar
• Elshenawy OH, El-Kadi AO. 2015a. Modulation of aryl hydrocarbon receptor-regulated enzymes by trimethylarsine oxide in C57BL/6 mice: in vivo and in vitro studies. Toxicol Lett. 238(1):17–31. doi:10.1016/j.toxlet.2015.06.1646.
   PubMed Web of Science ®Google Scholar
• Elshenawy OH, El-Kadi AO. 2015b. Modulation of aryl hydrocarbon receptor regulated genes by acute administration of trimethylarsine oxide in the lung, kidney and heart of C57BL/6 mice. Xenobiotica. 45(10):930–943. Epub 2015/06/05. doi:10.3109/00498254.2015.1032385.
   PubMed Web of Science ®Google Scholar
• Falkner KC, McCallum GP, Cherian MG, Bend JR. 1993. Effects of acute sodium arsenite administration on the pulmonary chemical metabolizing enzymes, cytochrome P-450 monooxygenase, NAD(P)H:quinone acceptor oxidoreductase and glutathione S-transferase in guinea pig: comparison with effects in liver and kidney. Chem Biol Interact. 86(1):51–68. doi:10.1016/0009-2797(93)90111-b.
   PubMed Web of Science ®Google Scholar
• Jacobs JM, Marek D, Walton HS, Sinclair PR, Sinclair JF. 1999. Effect of sodium arsenite on heme metabolism in cultured chick embryo hepatocytes. Arch Biochem Biophys. 371(1):8–14. doi:10.1006/abbi.1999.1416.
   PubMed Web of Science ®Google Scholar
• Jacobs JM, Nichols CE, Andrew AS, Marek DE, Wood SG, Sinclair PR, Wrighton SA, Kostrubsky VE, Sinclair JF. 1999. Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol. 157(1):51–59. doi:10.1006/taap.1999.8659.
   PubMed Web of Science ®Google Scholar
• Jacobs JM, Nichols C, Marek D, Gorman N, Walton HS, Sinclair PR, Sinclair JF. 2000. Effect of arsenite on the induction of CYP1A4 and CYP1A5 in cultured chick embryo hepatocytes. Toxicol Appl Pharmacol. 168:177–182. doi:10.1006/taap.2000.9017.
   PubMed Web of Science ®Google Scholar
• Jacobs J, Roussel R, Roberts M, Marek D, Wood S, Walton H, Dwyer B, Sinclair P, Sinclair J. 1998. Effect of arsenite on induction of CYP1A and CYP2H in primary cultures of chick hepatocytes. Toxicol Appl Pharmacol. 150(2):376–382. doi:10.1006/taap.1998.8436.
   PubMed Web of Science ®Google Scholar
• Jorge-Nebert LF, Jiang Z, Chakraborty R, Watson J, Jin L, McGarvey ST, Deka R, Nebert DW. 2010. Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations. Hum Mutat. 31(1):27–40. Epub 2009/10/06. doi:10.1002/humu.21132
   PubMed Web of Science ®Google Scholar
• Kann S, Huang M-Y, Estes C, Reichard JF, Sartor MA, Xia Y, Puga A. 2005. Arsenite-induced aryl hydrocarbon receptor nuclear translocation results in additive induction of phase I genes and synergistic induction of phase II genes. Mol Pharmacol. 68(2):336–346. doi:10.1124/mol.105.011841.
   PubMed Web of Science ®Google Scholar
• Kumagai Y, Sumi D. 2007. Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol. 47(1):243–262. doi:10.1146/annurev.pharmtox.47.120505.105144.
   PubMed Web of Science ®Google Scholar
• Liu J, Kadiiska MB, Liu Y, Lu T, Qu W, Waalkes MP. 2001. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci. 61(2):314–320. Epub 2001/05/16. doi:10.1093/toxsci/61.2.314.
   PubMed Web of Science ®Google Scholar
• Liu J, Xie Y, Ducharme DMK, Shen J, Diwan BA, Merrick BA, Grissom SF, Tucker CJ, Paules RS, Tennant R, et al. 2006. Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ Health Perspect. 114(3):404–411. doi:10.1289/ehp.8534.
   PubMed Web of Science ®Google Scholar
• Maier A, Dalton TP, Puga A. 2000. Disruption of dioxin-inducible phase I and phase II gene expression patterns by cadmium, chromium, and arsenic. Mol Carcinog. 28(4):225–235. doi:10.1002/1098-2744(200008)28:4 < 225::AID-MC5 > 3.0.CO;2-O.
   PubMed Web of Science ®Google Scholar
• Maier A, Schumann BL, Chang X, Talaska G, Puga A. 2002. Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity. Mutat Res. 517(1–2):101–111. doi:10.1016/s1383-5718(02)00057-8.
   PubMed Web of Science ®Google Scholar
• Medina-Díaz IM, Estrada-Muñiz E, Reyes-Hernández OD, Ramírez P, Vega L, Elizondo G. 2009. Arsenite and its metabolites, MMA(III) and DMA(III), modify CYP3A4, PXR and RXR alpha expression in the small intestine of CYP3A4 transgenic mice. Toxicol Appl Pharmacol. 239(2):162–168. doi:10.1016/j.taap.2008.11.009.
   PubMed Web of Science ®Google Scholar
• Moe B, Peng H, Lu X, Chen B, Chen LWL, Gabos S, Li X-F, Le XC. 2016. Comparative cytotoxicity of fourteen trivalent and pentavalent arsenic species determined using real-time cell sensing. J Environ Sci. 49:113–124. doi:10.1016/j.jes.2016.10.004.
   Web of Science ®Google Scholar
• Naraharisetti SB, Aggarwal M, Sarkar SN, Malik JK. 2008. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes. Arch Toxicol. 82(8):543–551. doi:10.1007/s00204-008-0318-6.
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Wanibuchi H, Ogawa M, Kinoshita A, Morimura K, Hiroi T, Funae Y, Kishida H, Nakae D, Fukushima S, et al. 2002. Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: a possible reactive oxygen species mechanism. Int J Cancer. 100(2):136–139. doi:10.1002/ijc.10471.
   PubMed Web of Science ®Google Scholar
• Noreault-Conti TL, Jacobs JM, Trask HW, Wrighton SA, Sinclair JF, Nichols RC. 2006. Effect of proteasome inhibition on toxicity and CYP3A23 induction in cultured rat hepatocytes: comparison with arsenite. Toxicol Appl Pharmacol. 217(3):245–251. doi:10.1016/j.taap.2006.09.007.
   PubMed Web of Science ®Google Scholar
• Noreault TL, Jacobs JM, Nichols RC, Trask HW, Wrighton SA, Sinclair PR, Evans RM, Sinclair JF. 2005. Arsenite decreases CYP3A23 induction in cultured rat hepatocytes by transcriptional and translational mechanisms. Toxicol Appl Pharmacol. 209(2):174–182. doi:10.1016/j.taap.2005.04.008.
   PubMed Web of Science ®Google Scholar
• Noreault TL, Jacobs JM, Nichols RC, Trask HW, Wrighton SA, Sinclair PR, Sinclair JF. 2005. Mechanism of arsenite-mediated decreases in CYP3A23 in rat hepatocytes. Biochem Biophys Res Commun. 333(4):1211–1217. Epub 2005/06/28. doi:10.1016/j.bbrc.2005.05.194.
   PubMed Web of Science ®Google Scholar
• Noreault TL, Kostrubsky VE, Wood SG, Nichols RC, Strom SC, Trask HW, Wrighton SA, Evans RM, Jacobs JM, Sinclair PR, et al. 2005. Arsenite decreases CYP3A4 and RXRalpha in primary human hepatocytes. Drug Metab Dispos. 33(7):993–1003. doi:10.1124/dmd.105.003954.
   PubMed Web of Science ®Google Scholar
• Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM. 2011. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci. 120(Suppl 1):S49–S75. Epub 2010/11/10. PubMed PMID: 21059794; PubMed Central PMCID: PMC3145385. doi:10.1093/toxsci/kfq338.
   PubMed Web of Science ®Google Scholar
• Rajpoot DS, Prakash A, Mandil R, Rahal A, Garg SK. 2013. Differential modulation of xenobiotic-metabolizing enzymes in rats following single and concurrent exposure to chlorpyrifos, arsenic, and ascorbic acid. J Toxicol Environ Health A. 76(24):1354–1365. Epub 2013/11/29. doi:10.1080/15287394.2013.853005.
   PubMed Web of Science ®Google Scholar
• Ramanathan K, Shila S, Kumaran S, Panneerselvam C. 2003. Protective role of ascorbic acid and alpha-tocopherol on arsenic-induced microsomal dysfunctions. Hum Exp Toxicol. 22(3):129–136. Epub 2003/05/02. doi:10.1191/0960327103ht329oa.
   PubMed Web of Science ®Google Scholar
• Sardana MK, Drummond GS, Sassa S, Kappas A. 1981. The potent heme oxygenase inducing action of arsenic and parasiticidal arsenicals. Pharmacology. 23(5):247–253. Epub 1981/01/01. doi:10.1159/000137557.
   PubMed Web of Science ®Google Scholar
• Seubert JM, Sinal CJ, Bend JR. 2002. Acute sodium arsenite administration induces pulmonary CYP1A1 mRNA, protein and activity in the rat. J Biochem Mol Toxicol. 16(2):84–95. Epub 2002/04/30. doi:10.1002/jbt.10022.
   PubMed Web of Science ®Google Scholar
• Seubert JM, Webb CD, Bend JR. 2002. Acute sodium arsenite treatment induces Cyp2a5 but not Cyp1a1 in the C57Bl/6 mouse in a tissue (kidney) selective manner. J Biochem Mol Toxicol. 16(2):96–106. Epub 2002/04/30. doi:10.1002/jbt.10023.
   PubMed Web of Science ®Google Scholar
• Siller FR, Quintanilla-Vega B, Cebrián ME, Albores A. 1997. Effects of arsenite pretreatment on the acute toxicity of parathion. Toxicology. 116(1–3):59–65. Epub 1997/01/15. doi:10.1016/s0300-483x(96)03530-5.
   PubMed Web of Science ®Google Scholar
• Squires EJ, Sueyoshi T, Negishi M. 2004. Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J Biol Chem. 279(47):49307–49314. Epub 2004/09/07. doi:10.1074/jbc.M407281200.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu G, Cai Y. 2016. Thiolated arsenicals in arsenic metabolism: occurrence, formation, and biological implications. J Environ Sci. 49:59–73. Epub 2016/12/23. doi:10.1016/j.jes.2016.08.016.
   Web of Science ®Google Scholar
• Thompson ED, Burwinkel KE, Chava AK, Notch EG, Mayer GD. 2010. Activity of Phase I and Phase II enzymes of the benzo[a]pyrene transformation pathway in zebrafish (Danio rerio) following waterborne exposure to arsenite. Comp Biochem Physiol C Toxicol Pharmacol. 152(3):371–378. doi:10.1016/j.cbpc.2010.06.004.
   PubMed Web of Science ®Google Scholar
• van de Winkel A, Menke V, Capello A, Moons LMG, Pot RGJ, van Dekken H, Siersema PD, Kusters JG, van der Laan LJW, Kuipers EJ, et al. 2011. Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett’s esophagus and esophageal adenocarcinoma. BMC Gastroenterol. 11(1):108. Epub 2011/10/08. PubMed PMID: 21977915; PubMed Central PMCID: PMC3204292. doi:10.1186/1471-230x-11-108.
   PubMed Web of Science ®Google Scholar
• Wang QQ, Hua HY, Naranmandura H, Zhu HH. 2020. Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia. Toxicol Appl Pharmacol. 409:115299. Epub 2020/10/2 3 doi:10.1016/j.taap.2020.115299.
   PubMed Web of Science ®Google Scholar
• Wu JP, Chang LW, Yao HT, Chang H, Tsai HT, Tsai MH, Yeh TK, Lin P. 2009. Involvement of oxidative stress and activation of aryl hydrocarbon receptor in elevation of CYP1A1 expression and activity in lung cells and tissues by arsenic: an in vitro and in vivo study. Toxicol Sci. 107(2):385–393. doi:10.1093/toxsci/kfn239.
   PubMed Web of Science ®Google Scholar
• Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, Waalkes MP. 2007. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology. 236(1–2):7–15. Epub 2007/04/25. PubMed PMID: 17451858; PubMed Central PMCID: PMC2465467. doi:10.1016/j.tox.2007.03.021.
   PubMed Web of Science ®Google Scholar
• Yang HT, Chou HJ, Han BC, Huang SY. 2007. Lifelong inorganic arsenic compounds consumption affected blood pressure in rats. Food Chem Toxicol. 45(12):2479–2487. Epub 2007/08/11. doi:10.1016/j.fct.2007.05.024.
   PubMed Web of Science ®Google Scholar
• Zangar RC, Bollinger N, Verma S, Karin NJ, Lu Y. 2008. The nuclear factor-kappa B pathway regulates cytochrome P450 3A4 protein stability. Mol Pharmacol. 73(6):1652–1658. Epub 2008/03/13. doi:10.1124/mol.107.043976.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 138(1):103–141. Epub 2013/01/22. doi:10.1016/j.pharmthera.2012.12.007.
   PubMed Web of Science ®Google Scholar
• Zhao H, Wang Y, Guo M, Fei D, Mu M, Yu H, Xing M. 2019. Hepatoprotective effects of zinc (II) via cytochrome P-450/reactive oxygen species and canonical apoptosis pathways after arsenite waterborne exposure in common carp. Chemosphere. 236:124869. Epub 2019/09/25 doi:10.1016/j.chemosphere.2019.124869.
   PubMed Web of Science ®Google Scholar